People with milder asthma symptoms tend to fare better in the long-term if they start using inhaled steroids early on, a new study suggests.
Dr. William W. Busse, of the University of Wisconsin Medical School in Madison, led the study. Sweden-based AstraZeneca, which makes Pulmicort, funded the work.